Friday, February 13, 2009

OTC Select Announces NASDAQ End-of-Day Daily Stock Watch

OTC Select tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts by visiting OTC Select at the following: http://www.otcselect.com.

Today's end of day NASDAQ alerts include: Apple (NASDAQ: AAPL), Biogen (NASDAQ: BBIB), Cognizant Technology (NASDAQ:CTSH), Fastenal (NASDAQ: FAST), and Genzyme (NASDAQ: GENZ) and NetApp (NASDAQ: NTAP).

About Apple

Apple, Inc. designs, manufactures, and sells personal computers, portable digital music players, and mobile communication devices, as well as related software, services, peripherals, and networking solutions worldwide. The company’s products include desktop and notebook computers, server and storage products, and related devices and peripherals; Mac OS X operating system; and iLife, a suite of software for creation and management of digital photography, music, movies, DVDs, and Web site. In addition, it provides music products and services comprising iPod, portable digital music players and related accessories; online music services, third-party music, audio books, music videos, short films, television shows, movies, podcasts, and iPod games through its iTunes stores; and portable and desktop speaker systems, headphones, car radio solutions, voice recorders, cables and docks, power supplies and chargers, and carrying cases and armbands.

Further, the company sells peripheral products, including printers, storage devices, computer memory, digital video, and still cameras, as well as various other computing products and supplies. Additionally, Apple, Inc. offers various software products and computer technologies comprising Mac OS X operating system software; server software and related solutions; professional application software; and consumer, education, and business oriented application software. The company also provides Internet software and services comprising Safari, a Web browser; QuickTime, a multimedia software; Mac, a suite of Internet services. In addition, it offers wireless connectivity and networking services.

Apple, Inc., formerly known as Apple Computer, Inc., was founded in 1976. The company is headquartered in Cupertino, California.

About Biogen

Biogen Idec Inc., a biotechnology company, develops, manufactures, and commercializes novel therapeutics primarily in the areas of oncology, neurology, immunology, and cardiology in the United States and internationally. The company’s marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, low-grade or follicular, CD20-positive, and B-cell Non-Hodgkins Lymphoma (NHL); TYSABRI to treat relapsing MS; and FUMADERM for the treatment of severe psoriasis.

Its products under development consist of BG-12, a Phase III clinical trial product for the treatment of MS; Anti-CD80 MAb, a Phase III clinical trial product for the treatment of relapsed NHL; Anti-CD23 MAb, a Phase II/III clinical trial product for the treatment of relapsed or refractory chronic lymphocytic leukemia; Humanized Anti-CD20 MAb, a Phase III clinical trial product for the treatment of rheumatoid arthritis and lupus nephritis; Lixivaptan, a Phase III clinical drug for the treatment of Acute Hyponatremia; and ADENTRI, a Phase III clinical trial product for acute decompensated heart failure patients with renal insufficiency.

The company’s products under preclinical stage comprise BIIB014, Daclizumab, CDP323, Humanized Anti-CD20 MAb, PEG-IFN beta 1a, Neublastin, and LINGO for neurology; Volociximab, Hsp90 Inhibitor, GA101, Anti-IGF-1R, Anti-CRIPTO, RAF Inhibitor, and Anti-Fn14 for oncology; BG-12, Anti-TWEAK, Anti-CD40L Fab, and Anti-FcRn for autoimmune and inflammatory diseases; and ADENTRI and Aviptadil for cardiovascular diseases. It has collaboration agreements with Neurimmune SubOne AG; Cardiokine Biopharma LLC; mondoBIOTECH, AG; Alnylam Pharmaceuticals, Inc.; UCB, S.A.; Facet Biotech Corporation; Sunesis Pharmaceuticals, Inc.; Vernalis plc; Vetter Pharma-Fertigung GmbH & Co. KG; and Schering AG.

The company was founded in 1985 and is based in Cambridge, Massachusetts.


About Cognizant


Cognizant Technology Solutions Corporation provides information technology (IT) consulting and technology services, as well as outsourcing services in North America, Europe, and Asia. Its IT consulting and technology services include business process consulting; IT strategy consulting; technology consulting; application design, development, integration, and re-engineering; complex custom systems development; data warehousing/business intelligence; customer relationship management (CRM) system implementation; enterprise resource planning (ERP) system implementation; and software testing services.

The company’s outsourcing services comprise Application Maintenance, including custom application maintenance, and CRM and ERP maintenance; IT infrastructure outsourcing; and business process outsourcing. It offers its services to various markets, such as financial services, healthcare, manufacturing and logistics, retail, telecommunications, media and information services, and high technology.

The company was founded in 1994 and is headquartered in Teaneck, New Jersey.


About Fastenal

Fastenal Company, together with its subsidiaries, sells industrial and construction supplies. The company offers threaded fasteners, such as bolts, nuts, screws, studs, and related washers, as well as miscellaneous supplies, such as paints, various pins and machinery keys, concrete anchors, batteries, sealants, metal framing systems, wire ropes, struts, private-label stud anchors, rivets, and related accessories.

These products are used in manufactured products and building projects, and in the maintenance and repair of machines and structures. It also provides various tools and equipment; cutting tools and abrasives; hydraulics, pneumatics, plumbing, and HVAC products; material handling, storage, and packaging products; janitorial supplies, chemical, and paints; electrical supplies; welding supplies; safety supplies; and metals, alloys, and materials.

Fastenal Company offers its products to the customers in construction market, including general, electrical, plumbing, sheet metal, and road contractors, as well as in manufacturing market, which includes original equipment manufacturers, and maintenance and repair operations. Its other customers include farmers; truckers; railroads; mining companies; federal, state, and local governmental entities; schools; and certain retail trades. The company operates stores in 50 states of the United States, Puerto Rico, Canada, Mexico, Singapore, China, and the Netherlands.

Fastenal Company was founded in 1967 and is based in Winona, Minnesota.


About Genzyme

Genzyme Corporation operates as a biotechnology company worldwide. It operates through five segments: Renal, Therapeutics, Transplant, Biosurgery, and Genetics.

The Renal segment develops, manufactures, and distributes products for patients suffering from renal diseases, including chronic renal failure. This segment offers Renagel, a phosphate binder for the control of serum phosphorus in patients with chronic kidney disease (CKD) on hemodialysis; and Hectorol vitamin D2 pro-hormone products for the treatment of secondary hyperparathyroidism in patients with stages 3 and 4 CKD, and in patients with stage 5 CKD on dialysis.

The Therapeutics segment provides Cerezyme/Ceredase, an enzyme replacement therapy for the treatment of Gaucher disease; Fabrazyme, a recombinant form of the human enzyme alpha-galactosidase for the treatment of Fabry disease; Thyrogen, an adjunctive diagnostic agent used in the follow-up of patients with thyroid cancer; Myozyme therapy for Pompe disease; and Aldurazyme, a recombinant form of the human enzyme alpha-L-iduronidase to treat mucopolysaccharidosis I.

The Transplant segment offers Thymoglobulin, a polyclonal antibody that suppresses immune cells responsible for acute organ rejection in transplant patients.
The Biosurgery segment markets Synvisc, a biomaterial used to treat the pain associated with osteoarthritis of the knee; and Sepra products for preventing adhesions following various surgical procedures in the body.

The Genetics segment provides reproductive testing services, diagnostic services for reproductive and oncology markets, and genetic counseling services. It has a collaboration agreement with PTC Therapeutics, Inc. to develop and commercialize PTC124 for the treatment of genetic disorders due to nonsense mutations.

The company also has a strategic alliance with Osiris Therapeutics, Inc. to develop and commercialize Prochymal and Chondrogen. Genzyme Corporation was founded in 1981 and is based in Cambridge, Massachusetts.


About NetApp


NetApp, Inc. creates storage and data management solutions that accelerate business breakthroughs and deliver cost efficiency. The company principally offers a portfolio of solutions for business applications, storage for virtual servers, and disk-to-disk backup to its worldwide customers. Its solutions provide continuous availability of critical business data and simplify business processes to enable companies to deploy new capabilities.

The company offers solutions to protect its customers’ data, businesses, and reputations. It delivers services that help customers enhance what they are getting from their infrastructure. NetApp, Inc. provides support in local languages for global businesses. The company’s infrastructure solutions include archive and compliance, business continuity, disk-to-disk backup, storage consolidation, storage for virtualized environments, and test and development. Its application solutions comprise engineering and scientific, IBM Rational, Microsoft Exchange, Microsoft SharePoint, Microsoft SQL Server, Oracle, SAP, and Windows File Server. NetApp, Inc. serves energy, financial services, government, healthcare, life sciences, major manufacturing, media and Internet, and telco service provider industries.

The company, formerly known as Network Appliance, Inc., was founded in 1992 and is headquartered in Sunnyvale, California


ABOUT OTC Select


OTC Select is a stock watch website that provides free daily alerts on stocks. OTC Select's alerts include news releases or daily e-mails on stocks in all sectors of the market. These include stocks with high or low volume, penny stocks, stocks with technical indicators and much more. OTC Select tracks stocks that may be moving upwards or downwards. OTC Select also features companies on its website with research reports, analysis, and newsletters.

OTC Select is an independent electronic publication that provides information on selected publicly traded companies. OTC Select is not a registered investment advisor or broker-dealer. OTC Select including affiliates, officers, directors, contractors and employees may buy, sell or hold shares in any company mentioned herein and may profit in the event those shares increase or decrease in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

To join and start receiving our FREE e-mail alerts, please visit: http://www.otcselect.com/subscribe.html

No comments: